My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Ador Multi Products reports standalone net loss of Rs 0.01 crore in the March 2017 quarter
May 10,2017

Net loss of Ador Multi Products reported to Rs 0.01 crore in the quarter ended March 2017 as against net profit of Rs 0.14 crore during the previous quarter ended March 2016. Sales rose 17.61% to Rs 1.87 crore in the quarter ended March 2017 as against Rs 1.59 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 0.51 crore in the year ended March 2017 as against net loss of Rs 0.70 crore during the previous year ended March 2016. Sales rose 13.64% to Rs 6.50 crore in the year ended March 2017 as against Rs 5.72 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1.871.59 18 6.505.72 14 OPM %-18.72-13.84 --14.00-14.16 - PBDT-0.35-0.26 -35 0.99-0.96 LP PBT-0.38-0.30 -27 0.88-1.14 LP NP-0.010.14 PL 0.51-0.70 LP

Powered by Capital Market - Live News

NELCO standalone net profit rises 267.65% in the March 2017 quarter
May 10,2017

Net profit of NELCO rose 267.65% to Rs 2.50 crore in the quarter ended March 2017 as against Rs 0.68 crore during the previous quarter ended March 2016. Sales rose 1.46% to Rs 21.52 crore in the quarter ended March 2017 as against Rs 21.21 crore during the previous quarter ended March 2016.

For the full year,net profit rose 401.50% to Rs 6.67 crore in the year ended March 2017 as against Rs 1.33 crore during the previous year ended March 2016. Sales declined 32.90% to Rs 89.39 crore in the year ended March 2017 as against Rs 133.21 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales21.5221.21 1 89.39133.21 -33 OPM %2.2311.74 -11.0110.43 - PBDT3.771.76 114 11.318.40 35 PBT2.500.68 268 6.671.33 402 NP2.500.68 268 6.671.33 402

Powered by Capital Market - Live News

Astrazeneca Pharma India reports standalone net loss of Rs 2.88 crore in the March 2017 quarter
May 10,2017

Net loss of Astrazeneca Pharma India reported to Rs 2.88 crore in the quarter ended March 2017 as against net profit of Rs 0.56 crore during the previous quarter ended March 2016. Sales declined 16.90% to Rs 110.95 crore in the quarter ended March 2017 as against Rs 133.51 crore during the previous quarter ended March 2016.

For the full year,net profit rose 364.64% to Rs 24.44 crore in the year ended March 2017 as against Rs 5.26 crore during the previous year ended March 2016. Sales declined 0.03% to Rs 526.31 crore in the year ended March 2017 as against Rs 526.46 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales110.95133.51 -17 526.31526.46 0 OPM %-4.282.40 -5.583.12 - PBDT1.685.30 -68 49.0323.19 111 PBT-2.001.06 PL 33.205.76 476 NP-2.880.56 PL 24.445.26 365

Powered by Capital Market - Live News

La Opala RG standalone net profit declines 5.27% in the March 2017 quarter
May 10,2017

Net profit of La Opala RG declined 5.27% to Rs 13.47 crore in the quarter ended March 2017 as against Rs 14.22 crore during the previous quarter ended March 2016. Sales rose 41.04% to Rs 75.02 crore in the quarter ended March 2017 as against Rs 53.19 crore during the previous quarter ended March 2016.

For the full year,net profit declined 6.40% to Rs 54.95 crore in the year ended March 2017 as against Rs 58.71 crore during the previous year ended March 2016. Sales rose 5.39% to Rs 259.68 crore in the year ended March 2017 as against Rs 246.40 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales75.0253.19 41 259.68246.40 5 OPM %27.6138.41 -33.6135.08 - PBDT20.7620.54 1 87.3986.90 1 PBT17.2517.81 -3 74.9277.92 -4 NP13.4714.22 -5 54.9558.71 -6

Powered by Capital Market - Live News

Ador Welding standalone net profit declines 12.17% in the March 2017 quarter
May 10,2017

Net profit of Ador Welding declined 12.17% to Rs 7.58 crore in the quarter ended March 2017 as against Rs 8.63 crore during the previous quarter ended March 2016. Sales rose 5.11% to Rs 158.92 crore in the quarter ended March 2017 as against Rs 151.20 crore during the previous quarter ended March 2016.

For the full year,net profit declined 17.57% to Rs 18.67 crore in the year ended March 2017 as against Rs 22.65 crore during the previous year ended March 2016. Sales rose 8.29% to Rs 440.57 crore in the year ended March 2017 as against Rs 406.83 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales158.92151.20 5 440.57406.83 8 OPM %6.329.52 -7.0210.01 - PBDT13.9815.42 -9 39.3445.44 -13 PBT11.2212.56 -11 28.1233.78 -17 NP7.588.63 -12 18.6722.65 -18

Powered by Capital Market - Live News

Carborundum Universal standalone net profit rises 52.14% in the March 2017 quarter
May 10,2017

Net profit of Carborundum Universal rose 52.14% to Rs 45.40 crore in the quarter ended March 2017 as against Rs 29.84 crore during the previous quarter ended March 2016. Sales rose 8.56% to Rs 370.58 crore in the quarter ended March 2017 as against Rs 341.36 crore during the previous quarter ended March 2016.

For the full year,net profit rose 4.59% to Rs 121.77 crore in the year ended March 2017 as against Rs 116.43 crore during the previous year ended March 2016. Sales rose 8.58% to Rs 1382.77 crore in the year ended March 2017 as against Rs 1273.53 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales370.58341.36 9 1382.771273.53 9 OPM %15.6616.34 -15.5515.59 - PBDT76.4860.19 27 237.64229.55 4 PBT59.6344.27 35 170.70167.48 2 NP45.4029.84 52 121.77116.43 5

Powered by Capital Market - Live News

Onward Technologies appoints director
May 10,2017

Onward Technologies announced that the Board of Directors of the Company have appointed Parish Meghani as an Additional Director (Non Executive / Independent) effective from 10 May 2017.

Powered by Capital Market - Live News

Ador Multi Products reports consolidated net loss of Rs 0.29 crore in the March 2017 quarter
May 10,2017

Net loss of Ador Multi Products reported to Rs 0.29 crore in the quarter ended March 2017. There were no net profit/loss reported during the previous quarter ended March 2016. Sales rose 20.13% to Rs 1.91 crore in the quarter ended March 2017 as against Rs 1.59 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 0.24 crore in the year ended March 2017 as against net loss of Rs 0.88 crore during the previous year ended March 2016. Sales rose 15.91% to Rs 6.63 crore in the year ended March 2017 as against Rs 5.72 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1.911.59 20 6.635.72 16 OPM %-25.13-22.64 --20.51-17.31 - PBDT-0.48-0.40 -20 0.59-1.14 LP PBT-0.50-0.44 -14 0.45-1.33 LP NP-0.290 0 0.24-0.88 LP

Powered by Capital Market - Live News

NELCO consolidated net profit declines 62.16% in the March 2017 quarter
May 10,2017

Net profit of NELCO declined 62.16% to Rs 0.98 crore in the quarter ended March 2017 as against Rs 2.59 crore during the previous quarter ended March 2016. Sales rose 6.75% to Rs 36.99 crore in the quarter ended March 2017 as against Rs 34.65 crore during the previous quarter ended March 2016.

For the full year,net profit rose 184.16% to Rs 6.28 crore in the year ended March 2017 as against Rs 2.21 crore during the previous year ended March 2016. Sales declined 28.14% to Rs 143.67 crore in the year ended March 2017 as against Rs 199.94 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales36.9934.65 7 143.67199.94 -28 OPM %9.8414.34 -12.6210.87 - PBDT3.674.33 -15 14.9513.32 12 PBT1.572.59 -39 6.932.21 214 NP0.982.59 -62 6.282.21 184

Powered by Capital Market - Live News

Blue Star consolidated net profit rises 147.63% in the March 2017 quarter
May 10,2017

Net profit of Blue Star rose 147.63% to Rs 37.17 crore in the quarter ended March 2017 as against Rs 15.01 crore during the previous quarter ended March 2016. Sales rose 18.56% to Rs 1371.79 crore in the quarter ended March 2017 as against Rs 1157.05 crore during the previous quarter ended March 2016.

For the full year,net profit rose 17.44% to Rs 123.05 crore in the year ended March 2017 as against Rs 104.78 crore during the previous year ended March 2016. Sales rose 15.53% to Rs 4387.73 crore in the year ended March 2017 as against Rs 3797.96 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1371.791157.05 19 4387.733797.96 16 OPM %5.245.20 -5.075.66 - PBDT67.9660.02 13 219.21201.45 9 PBT51.3842.37 21 158.63144.36 10 NP37.1715.01 148 123.05104.78 17

Powered by Capital Market - Live News

Marksans Pharma leads gainers on BSEs A group
May 10,2017

Marksans Pharma rose 13.81% at Rs 54.80. The stock topped the gainers in A group. On the BSE, 32.21 lakh shares were traded on the counter so far as against the average daily volumes of 4.74 lakh shares in the past two weeks.

Gujarat Mineral Development Corporation (GMDC) rose 7.33% at Rs 134.65. The stock was the second biggest gainer in A group. On the BSE, 10.84 lakh shares were traded on the counter so far as against the average daily volumes of 46,000 shares in the past two weeks.

Escorts rose 7.04% at Rs 642. The stock was the third biggest gainer in A group. On the BSE, 9.69 lakh shares were traded on the counter so far as against the average daily volumes of 2.19 lakh shares in the past two weeks.

CG Power and Industrial Solutions rose 5.33% at Rs 87.95. The stock was the fourth biggest gainer in A group. On the BSE, 12.38 lakh shares were traded on the counter so far as against the average daily volumes of 3.29 lakh shares in the past two weeks.

Bharti Airtel rose 4.80% at Rs 362.10. The stock was the fifth biggest gainer in A group. On the BSE, 7.57 lakh shares were traded on the counter so far as against the average daily volumes of 1.16 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Bitter pill for AstraZeneca Pharma after reverse turnaround in Q4
May 10,2017

The result was announced after market hours yesterday, 9 May 2017.

Meanwhile, the S&P BSE Sensex was up 263.29 points, or 0.88%, to 30,196.54. The S&P BSE Small-Cap index was up 130.87 points, or 0.84% to 15,675.50

On the BSE, 7,662 shares were traded on the counter so far as against the average daily volumes of 6,031 shares in the past one quarter. The stock had hit a high of Rs 968 and a low of Rs 945 so far during the day. The stock had hit a 52-week high of Rs 1,151 on 9 May 2016 and a 52-week low of Rs 909 on 1 March 2017.

The stock had outperformed the market over the past one month till 9 May 2017, rising 2.76% compared with 1.21% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, gaining 5.09% as against Sensexs 5.81% rise.

The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

AstraZeneca Pharma Indias total income dropped 26.66% to Rs 118.01 crore in Q4 March 2017 over Q4 March 2016.

AstraZeneca Pharma India is engaged in the development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. AstraZeneca Pharmaceuticals AB holds 75% stake in AstraZeneca Pharma India (as per the shareholding pattern as on 31 March 2017).

Powered by Capital Market - Live News

Premco Global consolidated net profit declines 59.24% in the March 2017 quarter
May 10,2017

Net profit of Premco Global declined 59.24% to Rs 1.39 crore in the quarter ended March 2017 as against Rs 3.41 crore during the previous quarter ended March 2016. Sales rose 7.22% to Rs 15.74 crore in the quarter ended March 2017 as against Rs 14.68 crore during the previous quarter ended March 2016.

For the full year,net profit declined 33.99% to Rs 8.33 crore in the year ended March 2017 as against Rs 12.62 crore during the previous year ended March 2016. Sales rose 1.93% to Rs 71.47 crore in the year ended March 2017 as against Rs 70.12 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales15.7414.68 7 71.4770.12 2 OPM %26.8739.37 -23.8728.65 - PBDT3.206.11 -48 16.2721.68 -25 PBT2.435.53 -56 13.3319.47 -32 NP1.393.41 -59 8.3312.62 -34

Powered by Capital Market - Live News

Alembic consolidated net profit rises 21.98% in the March 2017 quarter
May 10,2017

Net profit of Alembic rose 21.98% to Rs 30.24 crore in the quarter ended March 2017 as against Rs 24.79 crore during the previous quarter ended March 2016. Sales rose 18.80% to Rs 32.92 crore in the quarter ended March 2017 as against Rs 27.71 crore during the previous quarter ended March 2016.

For the full year,net profit declined 38.00% to Rs 145.39 crore in the year ended March 2017 as against Rs 234.51 crore during the previous year ended March 2016. Sales rose 7.59% to Rs 144.26 crore in the year ended March 2017 as against Rs 134.08 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales32.9227.71 19 144.26134.08 8 OPM %4.80-5.95 -4.664.56 - PBDT4.580.57 704 37.5334.69 8 PBT3.31-1.82 LP 32.4428.55 14 NP30.2424.79 22 145.39234.51 -38

Powered by Capital Market - Live News

Tata Motors announces Group global wholesale figures
May 10,2017

Tata Motors Group global wholesales in April 2017, including Jaguar LandRover, were at 73,691 nos., lower by 4%, over April 2016.

Global wholesales of all Tata Motors commercial vehicles and Tata Daewoo range in April 2017 were at 18,844 nos., lower by 36%, over April 2016.

Global wholesales of all passenger vehicles in April 2017 were at 54,847 nos., higher by 16%, compared to April 2016.

Global wholesales for Jaguar Land Rover were 41,923 vehicles. Jaguar wholesales for the month were 12,608 vehicles, while Land Roverwholesales for the month were 29,315 vehicles.

Powered by Capital Market - Live News